These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11713429)

  • 1. Minimally invasive application of botulinum toxin type A in nasal hypersecretion.
    Rohrbach S; Laskawi R
    ORL J Otorhinolaryngol Relat Spec; 2001; 63(6):382-4. PubMed ID: 11713429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis.
    Rohrbach S; Junghans K; Köhler S; Laskawi R
    Head Face Med; 2009 Oct; 5():18. PubMed ID: 19835591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin for Rhinitis.
    Ozcan C; Ismi O
    Curr Allergy Asthma Rep; 2016 Aug; 16(8):58. PubMed ID: 27461136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of botulinum toxin A in chronic intrinsic rhinitis].
    Nowak K; Szyfter W
    Otolaryngol Pol; 2011; 65(2):103-5. PubMed ID: 21735664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia.
    Sapci T; Yazici S; Evcimik MF; Bozkurt Z; Karavus A; Ugurlu B; Ozkurt E
    Rhinology; 2008 Mar; 46(1):45-51. PubMed ID: 18444492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botolinum toxin in rhinitis: Literature review and posterior nasal injection in allergic rhinitis.
    Zhang EZ; Tan S; Loh I
    Laryngoscope; 2017 Nov; 127(11):2447-2454. PubMed ID: 28681969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of botulinum toxin type A on vasomotor rhinitis and morphological study].
    Wang J; Chen F; Meng M; Zhang X; Chen Y; Huang W; Wang Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Nov; 17(11):643-5. PubMed ID: 14971193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy.
    Arikan OK; Tan FU; Kendi T; Koc C
    J Otolaryngol; 2006 Feb; 35(1):40-3. PubMed ID: 16527016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regarding the treatment of dynamic nasal tip ptosis with botulinum toxin A.
    Ghavami A; Janis JE; Guyuron B
    Plast Reconstr Surg; 2006 Jul; 118(1):263-4. PubMed ID: 16816709
    [No Abstract]   [Full Text] [Related]  

  • 10. [Using botulinum toxin (Botox) for treatment of patients with postroke spasticity].
    Khat'kova SE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):87-90. PubMed ID: 19685598
    [No Abstract]   [Full Text] [Related]  

  • 11. [Research progress of botulinum toxin type A in the treatment of chronic rhinitis].
    Zhang Y; Wang G
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Nov; 36(11):878-883. PubMed ID: 36347585
    [No Abstract]   [Full Text] [Related]  

  • 12. [Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology].
    Bernhard MK; Bertsche A; Syrbe S; Weise S; Merkenschlager A
    Fortschr Neurol Psychiatr; 2014 Jan; 82(1):39-42. PubMed ID: 24446117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach.
    Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B
    Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis.
    Ozcan C; Vayisoglu Y; Doğu O; Görür K
    Am J Otolaryngol; 2006; 27(5):314-8. PubMed ID: 16935174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of compensatory hyperhidrosis with botulinum toxin type A.
    Belin EE; Polo J
    Cutis; 2003 Jan; 71(1):68-70. PubMed ID: 12553633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frey syndrome: treatment with type A botulinum toxin.
    von Lindern JJ; Niederhagen B; Bergé S; Hägler G; Reich RH
    Cancer; 2000 Oct; 89(8):1659-63. PubMed ID: 11042557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of botulinum toxin type A injection for intrinsic rhinitis.
    Kim KS; Kim SS; Yoon JH; Han JW
    J Laryngol Otol; 1998 Mar; 112(3):248-51. PubMed ID: 9624373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and efficacy of botulinum toxin in hemifacial spasm].
    Mazlout H; Kamoun Gargouri H; Triki W; Kéfi S; Brour J; El Afrit MA; Chéour M; Kraiem A
    J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Septal injection of botulinum neurotoxin A for idiopathic rhinitis: a pilot study.
    Braun T; Gürkov R; Kramer MF; Krause E
    Am J Otolaryngol; 2012; 33(1):64-7. PubMed ID: 21419514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
    Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.